131 related articles for article (PubMed ID: 17049844)
1. A selective androgen receptor modulator that reduces prostate tumor size and prevents orchidectomy-induced bone loss in rats.
Allan G; Lai MT; Sbriscia T; Linton O; Haynes-Johnson D; Bhattacharjee S; Dodds R; Fiordeliso J; Lanter J; Sui Z; Lundeen S
J Steroid Biochem Mol Biol; 2007 Jan; 103(1):76-83. PubMed ID: 17049844
[TBL] [Abstract][Full Text] [Related]
2. A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats.
Allan G; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Ng R; Sui Z; Lundeen S
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):207-13. PubMed ID: 18502117
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
[TBL] [Abstract][Full Text] [Related]
4. A selective androgen receptor modulator with minimal prostate hypertrophic activity enhances lean body mass in male rats and stimulates sexual behavior in female rats.
Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Zhang X; Sui Z; Lundeen SG
Endocrine; 2007 Aug; 32(1):41-51. PubMed ID: 17992601
[TBL] [Abstract][Full Text] [Related]
5. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
[TBL] [Abstract][Full Text] [Related]
6. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
7. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE
J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747
[TBL] [Abstract][Full Text] [Related]
8. Steroid derivatives as pure antagonists of the androgen receptor.
Gauthier S; Martel C; Labrie F
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):93-104. PubMed ID: 22449547
[TBL] [Abstract][Full Text] [Related]
9. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement.
Vanderschueren D; Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R
Endocrinology; 2000 May; 141(5):1642-7. PubMed ID: 10803572
[TBL] [Abstract][Full Text] [Related]
10. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
[TBL] [Abstract][Full Text] [Related]
11. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of bicalutamide (Casodex) versus orchidectomy on bone mineral density, bone remodelling, and bone biomechanics in healthy rats.
Lefort M; Díaz Curiel M; Carrascal MT; Méndez-Dávila C; de la Piedra C
Urol Int; 2005; 74(4):301-7. PubMed ID: 15897693
[TBL] [Abstract][Full Text] [Related]
13. A novel synthetic androgen receptor ligand, S42, works as a selective androgen receptor modulator and possesses metabolic effects with little impact on the prostate.
Min L; Yanase T; Tanaka T; Fan W; Nomura M; Kawate H; Okabe T; Takayanagi R; Nawata H
Endocrinology; 2009 Dec; 150(12):5606-16. PubMed ID: 19854864
[TBL] [Abstract][Full Text] [Related]
14. Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model.
Venken K; Boonen S; Van Herck E; Vandenput L; Kumar N; Sitruk-Ware R; Sundaram K; Bouillon R; Vanderschueren D
Bone; 2005 Apr; 36(4):663-70. PubMed ID: 15784189
[TBL] [Abstract][Full Text] [Related]
15. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
[TBL] [Abstract][Full Text] [Related]
16. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Miner JN; Chang W; Chapman MS; Finn PD; Hong MH; López FJ; Marschke KB; Rosen J; Schrader W; Turner R; van Oeveren A; Viveros H; Zhi L; Negro-Vilar A
Endocrinology; 2007 Jan; 148(1):363-73. PubMed ID: 17023534
[TBL] [Abstract][Full Text] [Related]
17. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.
Seidlová-Wuttke D; Jarry H; Pitzel L; Wuttke W
Maturitas; 2005 Jun; 51(2):177-86. PubMed ID: 15917159
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
[TBL] [Abstract][Full Text] [Related]
19. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
20. Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.
Attar RM; Jure-Kunkel M; Balog A; Cvijic ME; Dell-John J; Rizzo CA; Schweizer L; Spires TE; Platero JS; Obermeier M; Shan W; Salvati ME; Foster WR; Dinchuk J; Chen SJ; Vite G; Kramer R; Gottardis MM
Cancer Res; 2009 Aug; 69(16):6522-30. PubMed ID: 19654297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
